Literature DB >> 20844022

Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy.

Xiaohua Wang1, Yang Zhou, Ruoyun Tan, Mingxia Xiong, Weichun He, Li Fang, Ping Wen, Lei Jiang, Junwei Yang.   

Abstract

Matrix metalloproteinase-9 (MMP-9) is one of the major components of the matrix proteolytic network, and its role in the pathogenesis of renal interstitial fibrosis remains largely unknown. Here, we demonstrate that ablation of MMP-9 attenuated renal interstitial fibrotic lesions in obstructive nephropathy. Mice lacking MMP-9 were less likely to develop morphological injury, which was characterized by a reduced disruption of tubular basement membrane (TBM) and expression of fibronectin as well as deposition of total tissue collagen in the kidneys after sustained ureteral obstruction compared with their wild-type counterparts. Deficiency of MMP-9 blocked tubular epithelial-to-myofibroblast transition (EMT) but did not alter the induction of transforming growth factor (TGF)-β1 axis expression in the obstructed kidneys. In vitro, TBM, which was digested by MMP-9 instead of MMP-9 itself, induces EMT and enhances migration of transformed cells. Thus increased MMP-9 is detrimental in renal interstitial fibrogenesis through a cascade of events that leads to TBM destruction and in turn to promotion of EMT. Our findings establish a crucial and definite importance of MMP-9 in the pathogenesis of renal interstitial fibrosis at the whole-animal level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844022     DOI: 10.1152/ajprenal.00216.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  44 in total

Review 1.  Fetal genitourinary imaging.

Authors:  Teresa Chapman
Journal:  Pediatr Radiol       Date:  2012-03-06

Review 2.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

Review 3.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

Review 4.  Resolution of organ fibrosis.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

5.  Matrix metalloproteinases in ureteropelvic junction obstruction.

Authors:  A Pavlaki; N Printza; E Farmaki; S Stabouli; A Taparkou; J Dotis; F Papachristou
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

Review 6.  Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases.

Authors:  Hong Zhao; Yanting Dong; Xinrui Tian; Thian Kui Tan; Zhuola Liu; Ye Zhao; Yun Zhang; David Ch Harris; Guoping Zheng
Journal:  World J Nephrol       Date:  2013-08-06

7.  Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients.

Authors:  Marta Toni; José Hermida; María J Goñi; Patricia Fernández; William C Parks; Estefanía Toledo; Ramón Montes; Nieves Díez
Journal:  Diabetologia       Date:  2013-12       Impact factor: 10.122

Review 8.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

9.  Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.

Authors:  Dong Zhou; Yuan Tian; Ling Sun; Lili Zhou; Liangxiang Xiao; Roderick J Tan; Jianwei Tian; Haiyan Fu; Fan Fan Hou; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2016-09-13       Impact factor: 10.121

Review 10.  A glimpse of matrix metalloproteinases in diabetic nephropathy.

Authors:  X Xu; L Xiao; P Xiao; S Yang; G Chen; F Liu; Y S Kanwar; L Sun
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.